Question follow-through · 60036
Pregnancy: Drugs
To ask the Secretary of State for Health and Social Care, what assessment he has made of the adequacy of prescribing practices of medicines with known teratogenic properties.
About this written question
A written question asks a government minister for information in writing. Parliament publishes the question and any answer.
- Answering body
- Department of Health and Social Care
- Tabled
- 16 Jun 2025
- Target answer date
- 18 Jun 2025
- Answer
- 25 Jun 2025 · 9 calendar days after tabling
Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.
More questions by this MP on Health and care
- Sodium Valproate and Surgical Mesh Implants: Compensation · 17 Jun 2025
- Department of Health and Social Care: Parliamentary Commissioner for Administration · 23 Jun 2025
- Heart Diseases: Screening · 25 Jun 2025
- Heart Diseases: Health Services · 25 Jun 2025
- Health Services: Young People · 25 Jun 2025
Shared topic keywords suggest a connection; they do not establish a follow-up.
Votes on this topic
- Terminally Ill Adults (End of Life) Bill: Second Reading · 11 Sept 2026
- Health Bill: Report Stage: Amendment 1 · 8 Sept 2026
- Health Bill: Report Stage: New Clause 143 · 8 Sept 2026
These Commons divisions share a topic label. The question did not necessarily lead to a vote.
Recorded timeline
16 Jun 2025
Question tabled
To ask the Secretary of State for Health and Social Care, what assessment he has made of the adequacy of prescribing practices of medicines with known teratogenic properties.
18 Jun 2025
Target answer date
Date supplied by the official written-questions record.
25 Jun 2025
Answer published
Prescribers are expected to work with patients to make decisions about their care and treatment as part of shared decision-making, and this should include discussing risks, benefits, and possible consequences of different options. Where applicable, the ri...
Official data retrieved 28 Sept 2026.
Later records
Possible follow-up questions
Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.
Sodium Valproate and Surgical Mesh Implants: Compensation
17 Jun 2025 · To ask the Secretary of State for Health and Social Care, whether he plans to implement the compensation recommendations in the Hughes Report, published on 7 February 2024.
Department of Health and Social Care: Parliamentary Commissioner for Administration
23 Jun 2025 · To ask the Secretary of State for Health and Social Care, how many times his Department has accepted in full the position of the Parliamentary Ombudsman’s (a) findings and (b) recommendations on (i) issuing an apology and (ii) other forms of redress in th
Heart Diseases: Screening
25 Jun 2025 · To ask the Secretary of State for Health and Social Care, if he will take steps to increase cardiac screening for people with a familial risk of sudden cardiac death.
Heart Diseases: Health Services
25 Jun 2025 · To ask the Secretary of State for Health and Social Care, if he will conduct a review on the prevention of sudden cardiac death that includes (a) an estimation of the incidence of sudden cardiac death, (b) methods to (i) detect and (ii) minimise cardiac c
Health Services: Young People
25 Jun 2025 · To ask the Secretary of State for Health and Social Care, if he will implement a national youth health strategy to reduce mortality in people under 39 that includes (a) mental health conditions and (b) sudden cardiac death.
Heart Diseases: Young People
25 Jun 2025 · To ask the Secretary of State for Health and Social Care, when the National Screening Committee plans to publish an update to guidance on screening for sudden cardiac death in people under 39.
Cancer: Health Services
25 Jun 2025 · To ask the Secretary of State for Health and Social Care, what steps he has taken to (a) improve the early detection of cancer, (b) reduce cancer care waiting times and (c) increase cancer survival rates.
Prostate Cancer: Screening
25 Jun 2025 · To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of offering prostate cancer screening to men considered to be at high risk on (a) NHS costs and (b) health outcomes.
Foetal Valproate Spectrum Disorder: Health Services
8 Jul 2025 · To ask the Secretary of State for Health and Social Care, if he will take steps to ensure the provision of specialist training for healthcare professionals on (a) the symptoms of, (b) complications arising from and (c) available support for people affecte
Foetal Valproate Spectrum Disorder: Diagnosis
8 Jul 2025 · To ask the Secretary of State for Health and Social Care, what information his Department holds on the number of children who received a diagnosis of Foetal Valproate Spectrum Disorder between (a) January 2010 to 2015, (b) January 2015 to 2020 and (c) Jan
Sodium Valproate: Women
8 Jul 2025 · To ask the Secretary of State for Health and Social Care, what information his Department holds on the number of prescriptions for sodium valproate given to women between the ages of 18 and 52 in 2024.
Pregnancy: Epilepsy
8 Jul 2025 · To ask the Secretary of State for Health and Social Care, what steps he has taken to ensure the provisions of (a) education and (b) training to help midwives support pregnant women who have been diagnosed with epilepsy.